3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents

Archiv der Pharmazie
Mohamed S Al-SaadiHassan M Faidallah

Abstract

The synthetic strategies and characterization of some novel derivatives of 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]pyrazoles carrying different pharmacophores and heterocyclic rings that are relevant to potential antitumour and cytotoxic activities are described. The antitumour activities of the newly synthesized compounds were evaluated according to the protocol of the National Cancer Institute (NCI) in-vitro disease-oriented human cells screening panel assay. The results revealed that six compounds, namely 6, 8, 11, 15, 17 and 18; displayed promising in-vitro antitumour activity in the 60-cell lines assay. The sulfonylthioureido group emerged as the most favourable pharmacophore. Incorporating such thioureido counterpart into the 6-membered 1,3-thiazinan-5-one resulted in better antitumour activities than those displayed by the 5-membered thiazoles and the 6-membered 1,3-thiazinan-4-one ring systems. Further ring expansion led to a total loss of the antitumour activity. The analog 18, 3-benzyl-2-[4-(3-methyl-4,5-dihydronaphtho-[1,2-c]pyrazol-2-yl)-benzenesulfonylimino]-1,3-thiazinan-5-one, proved to be the most active member identified in this series of compounds (GI(50), TGI, and LC(50) MG-MID values of 34...Continue Reading

References

Jun 5, 1991·Journal of the National Cancer Institute·A MonksA Vaigro-Wolff
Jul 8, 1994·Journal of Medicinal Chemistry·E M ActonM R Boyd
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·J C MedinaJ C Jaen
Mar 4, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A Scozzafava, C T Supuran
Jul 12, 2000·European Journal of Medicinal Chemistry·M T CoccoV Onnis
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A MastrolorenzoC T Supuran
Aug 6, 2002·European Journal of Medicinal Chemistry·Pascal RathelotPatrice Vanelle
Feb 21, 2003·European Journal of Medicinal Chemistry·Adnan A BekhitAzza M Baraka
Apr 8, 2003·Current Medicinal Chemistry. Anti-cancer Agents·M F Braña, A Ramos
Mar 31, 2004·European Journal of Medicinal Chemistry·Giuseppe DaidoneDomenico Schillaci
Mar 5, 2005·Bioorganic & Medicinal Chemistry Letters·Ariamala GopalsamySridhar K Rabindran
Sep 20, 2005·Bioorganic & Medicinal Chemistry Letters·Sanjay Babu KatiyarPrem M S Chauhan
Oct 11, 2005·Bioorganic & Medicinal Chemistry·Scott H AllenKelly R Moniri
Nov 18, 2005·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Weiwei LiJoseph M Post
Nov 23, 2005·European Journal of Medicinal Chemistry·Alice M R BernardinoVeronica F Amaral
Oct 10, 2006·Archives of Pharmacal Research·Son-Hyok KwakSang-Hun Jung

❮ Previous
Next ❯

Citations

Nov 8, 2011·Acta Crystallographica. Section E, Structure Reports Online·Abdullah M AsiriEdward R T Tiekink
Jul 30, 2014·Journal of Enzyme Inhibition and Medicinal Chemistry·Ibrahim F NassarAbdel-Sattar S Hamad Elgazwy
Jul 19, 2012·Journal of Enzyme Inhibition and Medicinal Chemistry·Hassan M FaidallahSalem A Basaif
Nov 8, 2011·Acta Crystallographica. Section E, Structure Reports Online·Abdullah M AsiriEdward R T Tiekink
May 19, 2012·Acta Crystallographica. Section E, Structure Reports Online·Abdulrahman O Al-YoubiEdward R T Tiekink
May 17, 2012·Acta Crystallographica. Section E, Structure Reports Online·Abdulrahman O Al-YoubiEdward R T Tiekink
Jun 9, 2016·Chemistry : a European Journal·Laetitia MisticoJacques Maddaluno

❮ Previous
Next ❯